PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Jun-2022 Biophytis presents the development of Sarconeos (BIO101) in Phase 3 for the treatment of Sarcopenia at the 15th SCWD International Congress Biophytis
27-Jun-2022 Siemens Healthineers AG: Publication of a capital market information Siemens Healthineers AG
27-Jun-2022 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
27-Jun-2022 Ixaka and Minaris Regenerative Medicine Sign Tech Transfer and GMP Manufacturing Agreement for Lead Cell Therapy Candidate REX-001 B3C newswire
27-Jun-2022 Defence Therapeutics Inc.: DEFENCE REPORTS EFFECTIVE CONTROL OF CERVICAL CANCER GROWTH IN RESPONSE TO ITS ACCUVAC-PT007 THERAPEUTIC VACCINATION Defence Therapeutics Inc.
25-Jun-2022 MagForce AG issues Bearer Notes with a total Volume of up to EUR 3.5 Million to Lansdowne Investment Company Cyprus Limited MagForce AG
24-Jun-2022 FYB201, Formycon's biosimilar for Lucentis® (ranibizumab), receives CHMP recommendation from EMA Formycon AG
24-Jun-2022 ​​​​​​​PAION REPORTS SOLID PROGRESS WITH COMMERCIAL ACTIVITIES IN EUROPE PAION AG
24-Jun-2022 Kinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related Macular Degeneration and potential advantages of KIN001 Kinarus Therapeutics Holding AG
23-Jun-2022 Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in Australia Medacta Group SA
23-Jun-2022 Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer Adrenomed AG
23-Jun-2022 APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052 APONTIS PHARMA AG
23-Jun-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Positive Independent Data Safety Monitoring Board Recommendation for Phase 2b Study of Varoglutamstat in AD (news with additional features) Vivoryon Therapeutics N.V.
22-Jun-2022 Biophytis: Results of the Combined General Meeting on June 21, 2022 All ordinary and extraordinary resolutions presented by the company have been adopted Biophytis
22-Jun-2022 CureVac Announces Voting Results of General Meeting CureVac
22-Jun-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Outcome of Annual General Meeting 2022 (news with additional features) Vivoryon Therapeutics N.V.
22-Jun-2022 Evotec SE reports results of Annual General Meeting 2022 Evotec SE
22-Jun-2022 Besins Healthcare Group acquires hormonal gel manufacturing site Besins Healthcare
22-Jun-2022 Labcorp Enhances Clinical Trial and Drug Development Capabilities Through Real World Data Collaboration With HealthVerity Labcorp
22-Jun-2022 Truveta Announces Strategic Collaboration with Pfizer to Accelerate Safety Insights in Real Time Pfizer